News & Publications – Page 7 – Clinical Pharmaceutical Sciences

2025

January 23, 2025

An approach for improving the detection and quantitation of buprenorphine and its metabolites in maternal and neonatal hair

Alshogran OY, Zhao W, Krans EE, Caritis S, Shaik IH, Venkataramanan R.

Ther Drug Monit. 2025 Jun 1;47(3):413-420. DOI: 10.1097/FTD.0000000000001291. PMID: 39671206.

January 23, 2025

Pharmacogenetics: Opportunities for the All of Us Research Program and other large data sets to advance the field

Empey PE, Karnes JH, Johnson JA.

Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):111-130. DOI: 10.1146/annurev-pharmtox-061724-080718. PMID: 39847465.

January 22, 2025

Use of potentially nephrotoxic drugs in ype 2 diabetes patients on SGLT2i: a trajectories analysis

Yang L, Guo J, Kane-Gill SL, Gabriel N, Empey KM, Suh K, Kirisci L, Hernandez I.

Pharmacoepidemiol Drug Saf. 2025 Feb;34(2):e70098. DOI: 10.1002/pds.70098. PMID: 39842818.

January 21, 2025

Optimizing drug therapy during pregnancy: A spotlight on population pharmacokinetic modeling

Dodeja P, Chaphekar N, Caritis SN, Venkataramanan R.

Expert Opin Drug Metab Toxicol. 2025 Jan-Feb;21(2):143-160. DOI: 10.1080/17425255.2024.2420195. PMID: 39552350.

January 14, 2025

When patients present with direct-to-consumer pharmacogenomic test results

Donnelly RS, Ayoubieh H, Kudron EL, Mills M, Weiler T, Empey PE, Direct-to-Consumer Genetic Testing Project Group of the National Human Genome Research Institute Inter-Society Coordinating Committee for Practitioner Education in Genomics.

Mayo Clin Proc. 2025 Feb;100(2):197-203. DOI: 10.1016/j.mayocp.2024.10.016. PMID: 39818680.

January 3, 2025

Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir

Rai MA, Blazkova J, Kardava K, Justement JS, Shi V, Manning MR, Shahid A, Dong W, Kennedy BD, Sewack AB, Higgins J, Buckner CM, Gittens K, West RE, Devanathan AS, Mangusan R, Lurain K, Ramaswami R, Yarchoan R, Sneller MC, Pau AK, Brumme ZL, Moir S, Chun TW

Nat Med. 2025 Feb;31(2):427-432. DOI: 10.1038/s41591-024-03357-0. PMID: 39753965.

January 3, 2025

Integrating pharmacogenomics into the broader construct of genomic medicine: Efforts by the ClinGen Pharmacogenomics Working Group (PGxWG)

Gong L, Klein CJ, Caudle KE, Moyer AM, Scott SA, Whirl-Carrillo M, Klein TE, ClinGen Pharmacogenomics Working Group (PGxWG).

Clin Chem. 2025 Jan 3;71(1):36-44. DOI: 10.1093/clinchem/hvae181. PMID: 39749515.

2024

December 26, 2024

Longitudinal pharmacogenomic learning for student pharmacists

LeCompte K, Coons JC, Empey E, Berenbrok LA.

Curr Pharm Teach Learn. 2025 Mar;17(3):102189. DOI: 10.1016/j.cptl.2024.102189. PMID: 39729765.

December 2, 2024

The role of artificial intelligence and machine learning in accelerating the discovery and development of nanomedicine

Agrahari V, Choonara YE, Mosharraf M, Patel SK, Zhang F

Pharm Res. 2024 Dec;41(12):2289-2297. DOI: 10.1007/s11095-024-03798-9 PMID: 39623144

November 18, 2024

Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions

St Peter WL, Bzowyckyj AS, Anderson-Haag T, Awdishu L, Blackman M, Bland A, Chan E, Chmielewski C, Delgado C, Eyler R, Foster C, Hudson J, Kane-Gill SL, Kliethermes MA, Le T, Madabushi R, Martin B, Miller WG, Neumiller JJ, Philbrick AM, Roberts G, Schandorf V, Webb AJ, Wu D, Nolin TD; National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions.

Am J Health Syst Pharm. 2025 Jun 11;82(12):644-659. DOI: 10.1093/ajhp/zxae317. PMID: 39552516.

All Publications